Pfizer UK removes sales incentives for anti-infectives

Pfizer UK has changed how it incentivises its anti-infectives field-force under the drug giant’s commitment to the fight against antimicrobial resistance (AMR).

All sales have been ‘de-linked’ from its anti-infectives (AI) field-force incentives, with the focus now on measuring management-based objectives (MBOs) centering on generating access to medicines and promoting the appropriate use of antibiotics.